Mediterranean Journal of Hematology and Infectious Diseases (Jun 2021)
Ibrutinib associated cardiovascular events in a patient wearing an implanted loop recorder
Abstract
Ibrutinib is a well-tolerated and effective therapy used for the treatment of chronic lymphocytic leukemia (CLL). Its use has been associated with cardiovascular events such as atrial fibrillation (Afib), hypertension, and ventricular arrhythmias. Implanted loop recorders are a useful tool in guiding the management of patients with cardiac arrhythmias.
Keywords